Zinner RG - Search Results

1

Phase 1 clinical and pharmacokinetics evaluation of oral CI-1033 in patients with refractory cancer.

Nemunaitis J, Eiseman I, Cunningham C, Senzer N, Williams A, Lenehan PF, Olson SC, Bycott P, Schlicht M, Zentgraff R, Shin DM, Zinner RG. Nemunaitis J, et al. Among authors: zinner rg. Clin Cancer Res. 2005 May 15;11(10):3846-53. doi: 10.1158/1078-0432.CCR-04-1950. Clin Cancer Res. 2005. PMID: 15897585 Clinical Trial.

2

The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy.

Herbst RS, Khuri FR, Lu C, Liu DD, Fossella FV, Glisson BS, Pisters KM, Shin DM, Papadimitrakopoulou VA, Kurie JM, Blumenschein G Jr, Kies MS, Zinner R, Jung MS, Lu R, Lee JJ, Munden RF, Hong WK, Lee JS. Herbst RS, et al. Cancer. 2002 Jul 15;95(2):340-53. doi: 10.1002/cncr.10629. Cancer. 2002. PMID: 12124835 Free article. Clinical Trial.

3

Phase I study of the farnesyltransferase inhibitor BMS-214662 given weekly in patients with solid tumors.

Papadimitrakopoulou V, Agelaki S, Tran HT, Kies M, Gagel R, Zinner R, Kim E, Ayers G, Wright J, Khuri F. Papadimitrakopoulou V, et al. Clin Cancer Res. 2005 Jun 1;11(11):4151-9. doi: 10.1158/1078-0432.CCR-04-1659. Clin Cancer Res. 2005. PMID: 15930351 Clinical Trial.

4

A phase I evaluation of oral CI-1033 in combination with paclitaxel and carboplatin as first-line chemotherapy in patients with advanced non-small cell lung cancer.

Chiappori AA, Ellis PM, Hamm JT, Bitran JD, Eiseman I, Lovalvo J, Burnett D, Olson S, Lenehan P, Zinner RG. Chiappori AA, et al. Among authors: zinner rg. J Thorac Oncol. 2006 Nov;1(9):1010-9. J Thorac Oncol. 2006. PMID: 17409987 Free article. Clinical Trial.

5

Phase I clinical and pharmacodynamic evaluation of oral CI-1033 in patients with refractory cancer.

Zinner RG, Nemunaitis J, Eiseman I, Shin HJ, Olson SC, Christensen J, Huang X, Lenehan PF, Donato NJ, Shin DM. Zinner RG, et al. Clin Cancer Res. 2007 May 15;13(10):3006-14. doi: 10.1158/1078-0432.CCR-06-1958. Clin Cancer Res. 2007. PMID: 17505003 Clinical Trial.

6

Phase I trial of motexafin gadolinium in combination with docetaxel and cisplatin for the treatment of non-small cell lung cancer.

William WN Jr, Zinner RG, Karp DD, Oh YW, Glisson BS, Phan SC, Stewart DJ. William WN Jr, et al. Among authors: zinner rg. J Thorac Oncol. 2007 Aug;2(8):745-50. doi: 10.1097/JTO.0b013e31811f4719. J Thorac Oncol. 2007. PMID: 17762342 Free article. Clinical Trial.

7

Synergy between VEGF/VEGFR inhibitors and chemotherapy agents in the phase I clinic.

Tang C, Hess K, Jardim DL, Gagliato Dde M, Tsimberidou AM, Falchook G, Fu S, Janku F, Naing A, Piha-Paul S, Subbiah V, Wheler J, Zinner RG, Kurzrock R, Ellis LM, Meric-Berstam F, Hong DS. Tang C, et al. Among authors: zinner rg. Clin Cancer Res. 2014 Dec 1;20(23):5956-63. doi: 10.1158/1078-0432.CCR-14-1582. Epub 2014 Oct 14. Clin Cancer Res. 2014. PMID: 25316815 Clinical Trial.

8

A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination with the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid Cancers.

Kurzrock R, Ball DW, Zahurak ML, Nelkin BD, Subbiah V, Ahmed S, O'Connor A, Karunsena E, Parkinson RM, Bishop JA, Ha Y, Sharma R, Gocke CD, Zinner R, Rudek MA, Sherman SI, Azad NS. Kurzrock R, et al. Clin Cancer Res. 2019 Sep 15;25(18):5475-5484. doi: 10.1158/1078-0432.CCR-18-1881. Epub 2019 Jun 11. Clin Cancer Res. 2019. PMID: 31186313 Free PMC article. Clinical Trial.

9

Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer.

Zinner RG, Fossella FV, Gladish GW, Glisson BS, Blumenschein GR Jr, Papadimitrakopoulou VA, Pisters KM, Kim ES, Oh YW, Peeples BO, Ye Z, Curiel RE, Obasaju CK, Hong WK, Herbst RS. Zinner RG, et al. Cancer. 2005 Dec 1;104(11):2449-56. doi: 10.1002/cncr.21480. Cancer. 2005. PMID: 16258975 Free article. Clinical Trial.

10

Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck.

Tsao AS, Garden AS, Kies MS, Morrison W, Feng L, Lee JJ, Khuri F, Zinner R, Myers J, Papadimitrakopoulou V, Lewin J, Clayman GL, Ang KK, Glisson BS. Tsao AS, et al. J Clin Oncol. 2006 Sep 1;24(25):4163-9. doi: 10.1200/JCO.2006.05.7851. J Clin Oncol. 2006. PMID: 16943532 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters